Effectiveness of Hepatitis B Vaccination in Babies Born to Hepatitis B Surface Antigen–Positive Mothers in Italy

Citations Over TimeTop 10% of 2001 papers

Abstract

This study examined 522 children born to hepatitis B surface antigen (HBsAg)-positive mothers from 1985 through 1994 and evaluated the protection provided by anti-hepatitis B virus (HBV) immunization at birth. Babies were given hepatitis B immunoglobulin and hepatitis B vaccine at birth. At 5-14 years after immunization, 17 children (3.3%) were anti-HB core antigen positive, and 3 also were HBsAg positive. One carrier child had a double mutation, with substitution of proline-->serine at codons 120 (P120S) and 127 (P127S) within the a determinant of HBsAg. Of the 522 children, 400 (79.2%) of 505 still had protective anti-HBsAg titers > or =10 mIU/mL. Thus, HBV vaccination of children born to HBsAg-positive mothers is effective and confers long-term immunity. There is no evidence that the emergence of HBV escape mutants secondary to the immune pressure against wild-type HBV is of concern.

Related Papers

• → Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes(2009)142 cited
• → Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro(2012)54 cited
• → Evaluation of 10 commercial diagnostic kits for in vitro expressed hepatitis B virus (HBV) surface antigens encoded by HBV of genotypes A to H(2006)24 cited
• → Hepatitis B Virus Mutant Infections in Hemodialysis Patients: A Case Series(2019)5 cited
• Application of HBsAg and HBcAg Immune Fluorescence Detection in Diagnosis of Hepatitis B Virus Associated Glomerulonephritis(2010)